Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 201 | 2014 | 8861 | 4.630 |
Why?
|
Meningioma | 71 | 2012 | 1209 | 4.140 |
Why?
|
Neurosurgery | 41 | 2014 | 643 | 3.690 |
Why?
|
Meningeal Neoplasms | 55 | 2012 | 1241 | 3.300 |
Why?
|
Glioma | 84 | 2010 | 3401 | 2.790 |
Why?
|
Hydrocephalus, Normal Pressure | 17 | 2008 | 92 | 2.420 |
Why?
|
Cerebrospinal Fluid Shunts | 14 | 2010 | 189 | 1.640 |
Why?
|
Stereotaxic Techniques | 25 | 2014 | 536 | 1.540 |
Why?
|
Neurosurgical Procedures | 19 | 2011 | 2002 | 1.420 |
Why?
|
Glioblastoma | 52 | 2011 | 3481 | 1.340 |
Why?
|
Astrocytoma | 31 | 2011 | 790 | 1.290 |
Why?
|
Monitoring, Intraoperative | 14 | 2011 | 957 | 1.290 |
Why?
|
Pituitary Neoplasms | 28 | 2007 | 1345 | 1.190 |
Why?
|
Magnetic Resonance Imaging | 90 | 2014 | 35425 | 1.130 |
Why?
|
Craniotomy | 18 | 2011 | 729 | 0.990 |
Why?
|
Magnetic Resonance Spectroscopy | 15 | 2011 | 3759 | 0.940 |
Why?
|
Neuronavigation | 8 | 2011 | 167 | 0.910 |
Why?
|
Neuroma, Acoustic | 17 | 2009 | 451 | 0.730 |
Why?
|
Platelet-Derived Growth Factor | 10 | 2000 | 625 | 0.720 |
Why?
|
Hydrocephalus | 15 | 2010 | 748 | 0.720 |
Why?
|
Neovascularization, Pathologic | 19 | 2010 | 2638 | 0.710 |
Why?
|
Brain Diseases | 11 | 2012 | 1563 | 0.700 |
Why?
|
Adenoma | 18 | 2002 | 2174 | 0.660 |
Why?
|
Supratentorial Neoplasms | 6 | 2010 | 160 | 0.660 |
Why?
|
Radiosurgery | 23 | 2010 | 1329 | 0.650 |
Why?
|
Surgery, Computer-Assisted | 10 | 2014 | 1018 | 0.640 |
Why?
|
Intracranial Pressure | 10 | 2010 | 326 | 0.630 |
Why?
|
Oligodendroglioma | 9 | 2007 | 279 | 0.620 |
Why?
|
Receptors, Progesterone | 7 | 2008 | 1098 | 0.600 |
Why?
|
Spinal Cord Injuries | 14 | 2008 | 931 | 0.590 |
Why?
|
Intraoperative Care | 13 | 2009 | 767 | 0.550 |
Why?
|
Growth Substances | 5 | 2004 | 784 | 0.520 |
Why?
|
Hospitals, University | 3 | 2008 | 570 | 0.520 |
Why?
|
Humans | 411 | 2014 | 744366 | 0.500 |
Why?
|
Cerebrospinal Fluid | 7 | 2007 | 535 | 0.500 |
Why?
|
Skull Base Neoplasms | 3 | 2012 | 284 | 0.500 |
Why?
|
Image Processing, Computer-Assisted | 23 | 2010 | 8949 | 0.490 |
Why?
|
Loss of Heterozygosity | 6 | 2010 | 684 | 0.470 |
Why?
|
Societies, Medical | 5 | 2014 | 3743 | 0.450 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 9 | 2000 | 180 | 0.450 |
Why?
|
Adult | 198 | 2014 | 214052 | 0.450 |
Why?
|
Cerebral Ventricles | 11 | 2004 | 544 | 0.430 |
Why?
|
Brain | 51 | 2014 | 26388 | 0.430 |
Why?
|
Cerebellar Neoplasms | 7 | 2008 | 587 | 0.430 |
Why?
|
Male | 240 | 2014 | 350115 | 0.420 |
Why?
|
Epilepsies, Partial | 3 | 2008 | 436 | 0.420 |
Why?
|
RNA, Messenger | 26 | 2010 | 13035 | 0.400 |
Why?
|
History, 21st Century | 6 | 2014 | 1534 | 0.400 |
Why?
|
Tumor Cells, Cultured | 22 | 2007 | 6313 | 0.400 |
Why?
|
Middle Aged | 168 | 2014 | 213390 | 0.390 |
Why?
|
Mice, Nude | 25 | 2011 | 3689 | 0.390 |
Why?
|
Female | 226 | 2014 | 380193 | 0.390 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2010 | 8432 | 0.380 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2010 | 504 | 0.380 |
Why?
|
Angiogenesis Inhibitors | 10 | 2008 | 2038 | 0.380 |
Why?
|
Spinal Puncture | 5 | 2008 | 281 | 0.370 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2008 | 45 | 0.360 |
Why?
|
History, 20th Century | 16 | 2011 | 2740 | 0.360 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2009 | 182 | 0.360 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2008 | 415 | 0.360 |
Why?
|
Microsurgery | 2 | 2008 | 796 | 0.350 |
Why?
|
Aged | 132 | 2014 | 163288 | 0.350 |
Why?
|
Receptors, Androgen | 7 | 1997 | 1058 | 0.350 |
Why?
|
Imaging, Three-Dimensional | 11 | 2005 | 4042 | 0.340 |
Why?
|
Cerebral Cortex | 12 | 2009 | 5709 | 0.340 |
Why?
|
Ganglioglioma | 3 | 1997 | 42 | 0.330 |
Why?
|
Pituitary Diseases | 4 | 2002 | 141 | 0.330 |
Why?
|
Cerebrospinal Fluid Pressure | 3 | 2005 | 35 | 0.320 |
Why?
|
Neoplasm Recurrence, Local | 27 | 2013 | 9240 | 0.320 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2005 | 472 | 0.320 |
Why?
|
Blotting, Northern | 12 | 2001 | 1581 | 0.320 |
Why?
|
Anesthesia, Local | 3 | 2000 | 275 | 0.320 |
Why?
|
Medulloblastoma | 8 | 2006 | 683 | 0.310 |
Why?
|
Integrins | 3 | 2001 | 846 | 0.310 |
Why?
|
Drug Delivery Systems | 5 | 2010 | 2219 | 0.310 |
Why?
|
Peptide Fragments | 8 | 2007 | 5096 | 0.310 |
Why?
|
Tetrazolium Salts | 3 | 1998 | 96 | 0.310 |
Why?
|
Immunohistochemistry | 27 | 2012 | 11366 | 0.300 |
Why?
|
Surgery Department, Hospital | 1 | 2008 | 175 | 0.290 |
Why?
|
Endostatins | 7 | 2008 | 174 | 0.290 |
Why?
|
Neuroglia | 3 | 1997 | 928 | 0.290 |
Why?
|
Frontal Lobe | 9 | 2005 | 1406 | 0.290 |
Why?
|
Periodicals as Topic | 2 | 2014 | 1431 | 0.290 |
Why?
|
Brachytherapy | 13 | 2000 | 1248 | 0.280 |
Why?
|
Thrombophlebitis | 5 | 1987 | 309 | 0.280 |
Why?
|
Adolescent | 93 | 2012 | 85779 | 0.270 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 692 | 0.270 |
Why?
|
International Cooperation | 2 | 2010 | 1420 | 0.270 |
Why?
|
Software | 7 | 2011 | 4441 | 0.270 |
Why?
|
Combined Modality Therapy | 26 | 2010 | 8642 | 0.270 |
Why?
|
Teratoma | 1 | 2008 | 395 | 0.260 |
Why?
|
Neoplasm Metastasis | 5 | 2010 | 4851 | 0.260 |
Why?
|
Cell Division | 13 | 2004 | 4569 | 0.260 |
Why?
|
Cell Movement | 17 | 2011 | 5218 | 0.260 |
Why?
|
Postoperative Complications | 22 | 2008 | 15297 | 0.260 |
Why?
|
Plasminogen | 3 | 2000 | 152 | 0.250 |
Why?
|
Receptors, Vitronectin | 2 | 2001 | 52 | 0.250 |
Why?
|
Aspartic Acid | 2 | 2004 | 576 | 0.250 |
Why?
|
Conscious Sedation | 3 | 2000 | 528 | 0.250 |
Why?
|
Gene Expression | 10 | 2010 | 7798 | 0.250 |
Why?
|
Neoplasm Proteins | 6 | 2002 | 3707 | 0.250 |
Why?
|
Parietal Lobe | 8 | 2007 | 838 | 0.250 |
Why?
|
Treatment Outcome | 39 | 2014 | 63107 | 0.240 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 840 | 0.240 |
Why?
|
Epilepsy, Frontal Lobe | 2 | 2001 | 26 | 0.240 |
Why?
|
Neurology | 5 | 2001 | 763 | 0.240 |
Why?
|
Electroencephalography | 18 | 2008 | 6151 | 0.230 |
Why?
|
Iodine Radioisotopes | 7 | 1998 | 1032 | 0.230 |
Why?
|
Microsatellite Repeats | 5 | 1999 | 802 | 0.230 |
Why?
|
Neoplasm Staging | 10 | 2014 | 11031 | 0.230 |
Why?
|
Epilepsy, Temporal Lobe | 5 | 2002 | 403 | 0.230 |
Why?
|
Endothelial Growth Factors | 4 | 2000 | 694 | 0.230 |
Why?
|
Drainage | 2 | 2008 | 1142 | 0.230 |
Why?
|
Polymers | 2 | 2010 | 1621 | 0.230 |
Why?
|
Doxorubicin | 1 | 2010 | 2234 | 0.230 |
Why?
|
Child, Preschool | 43 | 2014 | 41005 | 0.230 |
Why?
|
Child | 66 | 2014 | 77709 | 0.230 |
Why?
|
Medical Oncology | 2 | 2007 | 2267 | 0.220 |
Why?
|
Epilepsy | 9 | 2014 | 3310 | 0.220 |
Why?
|
Receptors, Estrogen | 6 | 2008 | 2190 | 0.220 |
Why?
|
Contrast Media | 5 | 2008 | 5300 | 0.220 |
Why?
|
Surgical Equipment | 3 | 2004 | 57 | 0.220 |
Why?
|
Lymphokines | 4 | 2000 | 949 | 0.220 |
Why?
|
Biopsy | 15 | 2008 | 6755 | 0.220 |
Why?
|
Fibroblast Growth Factor 2 | 8 | 2008 | 599 | 0.220 |
Why?
|
Wounds, Nonpenetrating | 4 | 1994 | 795 | 0.210 |
Why?
|
Magnetic Resonance Angiography | 3 | 2004 | 1443 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 5 | 2009 | 2850 | 0.210 |
Why?
|
Receptors, Growth Factor | 3 | 2000 | 334 | 0.210 |
Why?
|
Rats | 32 | 2009 | 24252 | 0.210 |
Why?
|
Medical Illustration | 4 | 1991 | 133 | 0.210 |
Why?
|
Stem Cells | 8 | 2009 | 3567 | 0.210 |
Why?
|
Antineoplastic Agents | 16 | 2010 | 13693 | 0.210 |
Why?
|
Microspheres | 3 | 2010 | 777 | 0.200 |
Why?
|
Dacarbazine | 4 | 2009 | 566 | 0.200 |
Why?
|
Prognosis | 28 | 2011 | 29060 | 0.200 |
Why?
|
Magnetoencephalography | 2 | 2006 | 624 | 0.200 |
Why?
|
Aged, 80 and over | 42 | 2014 | 57776 | 0.200 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2011 | 3554 | 0.200 |
Why?
|
Pituitary Hormones, Anterior | 3 | 1998 | 65 | 0.200 |
Why?
|
Receptors, Cell Surface | 5 | 2000 | 2865 | 0.200 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2001 | 96 | 0.200 |
Why?
|
G(M3) Ganglioside | 1 | 2001 | 5 | 0.200 |
Why?
|
Pineal Gland | 2 | 1999 | 166 | 0.200 |
Why?
|
Malformations of Cortical Development | 3 | 2014 | 200 | 0.200 |
Why?
|
Preoperative Care | 6 | 2006 | 2251 | 0.200 |
Why?
|
Seizures | 6 | 2012 | 2859 | 0.200 |
Why?
|
Angiostatins | 4 | 2004 | 67 | 0.200 |
Why?
|
Telomerase | 4 | 2007 | 730 | 0.200 |
Why?
|
Genes, Neurofibromatosis 2 | 2 | 2012 | 124 | 0.190 |
Why?
|
Animals | 87 | 2014 | 168768 | 0.190 |
Why?
|
Neoplasm Transplantation | 14 | 2010 | 2086 | 0.190 |
Why?
|
Hospitals, Pediatric | 2 | 2008 | 1775 | 0.190 |
Why?
|
Pituitary Gland | 4 | 2001 | 665 | 0.190 |
Why?
|
Nitrobenzenes | 1 | 2000 | 65 | 0.190 |
Why?
|
Brain Death | 3 | 1991 | 348 | 0.190 |
Why?
|
Thiazoles | 4 | 2000 | 1483 | 0.190 |
Why?
|
Brain Mapping | 9 | 2010 | 6670 | 0.190 |
Why?
|
History, 19th Century | 6 | 2002 | 720 | 0.180 |
Why?
|
Blood Volume | 1 | 2002 | 565 | 0.180 |
Why?
|
Neurons | 10 | 2012 | 9340 | 0.180 |
Why?
|
DNA, Satellite | 2 | 2000 | 69 | 0.180 |
Why?
|
Cerebrovascular Circulation | 7 | 2004 | 2732 | 0.180 |
Why?
|
Collagen | 4 | 2001 | 2688 | 0.180 |
Why?
|
Ependymoma | 4 | 2007 | 334 | 0.180 |
Why?
|
Central Nervous System Neoplasms | 4 | 2008 | 895 | 0.180 |
Why?
|
Cell Cycle Proteins | 3 | 2001 | 3464 | 0.180 |
Why?
|
Microcomputers | 2 | 2004 | 147 | 0.180 |
Why?
|
Colorimetry | 3 | 1998 | 147 | 0.180 |
Why?
|
Ureter | 2 | 2013 | 375 | 0.180 |
Why?
|
Brain Edema | 3 | 1996 | 617 | 0.180 |
Why?
|
Evidence-Based Medicine | 4 | 2005 | 3611 | 0.180 |
Why?
|
Gadolinium DTPA | 3 | 2002 | 836 | 0.180 |
Why?
|
Receptors, Glucocorticoid | 3 | 1997 | 302 | 0.170 |
Why?
|
Disease Progression | 15 | 2012 | 13286 | 0.170 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 329 | 0.170 |
Why?
|
Hemangioma, Cavernous | 1 | 2000 | 110 | 0.170 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2010 | 3921 | 0.170 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2000 | 356 | 0.170 |
Why?
|
Oxazines | 1 | 2001 | 298 | 0.170 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 1999 | 25 | 0.170 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 2000 | 332 | 0.170 |
Why?
|
Spinal Cord Compression | 5 | 1993 | 235 | 0.170 |
Why?
|
Corpus Callosum | 2 | 1995 | 737 | 0.170 |
Why?
|
Apoptosis | 12 | 2007 | 9724 | 0.160 |
Why?
|
Genes, Tumor Suppressor | 3 | 2007 | 1097 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 4 | 2011 | 1632 | 0.160 |
Why?
|
Choline | 4 | 2004 | 493 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2009 | 3511 | 0.160 |
Why?
|
Urologic Neoplasms | 2 | 2013 | 318 | 0.160 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2000 | 371 | 0.160 |
Why?
|
Polymerase Chain Reaction | 12 | 2008 | 6171 | 0.160 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2000 | 282 | 0.160 |
Why?
|
Monitoring, Ambulatory | 1 | 2001 | 355 | 0.160 |
Why?
|
Teaching | 1 | 2006 | 1174 | 0.160 |
Why?
|
DNA, Neoplasm | 9 | 2007 | 1758 | 0.160 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 7 | 1998 | 1107 | 0.160 |
Why?
|
Thromboembolism | 2 | 2002 | 987 | 0.160 |
Why?
|
Isoenzymes | 3 | 2007 | 1728 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2014 | 2943 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 2 | 2002 | 1085 | 0.150 |
Why?
|
Oligodendroglia | 1 | 2001 | 517 | 0.150 |
Why?
|
Temporal Lobe | 10 | 2010 | 1670 | 0.150 |
Why?
|
Prolactin | 6 | 1999 | 669 | 0.150 |
Why?
|
Leukotriene C4 | 1 | 1998 | 97 | 0.150 |
Why?
|
Vascular Endothelial Growth Factors | 4 | 2000 | 772 | 0.150 |
Why?
|
Reoperation | 11 | 2014 | 4201 | 0.150 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2012 | 658 | 0.150 |
Why?
|
Cell Line, Tumor | 18 | 2014 | 16690 | 0.150 |
Why?
|
Leadership | 1 | 2007 | 1357 | 0.150 |
Why?
|
Patient Care Planning | 4 | 2001 | 921 | 0.150 |
Why?
|
X Chromosome | 3 | 1999 | 814 | 0.150 |
Why?
|
Spinal Cord | 11 | 2008 | 1810 | 0.150 |
Why?
|
Intraoperative Complications | 5 | 2007 | 1198 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 26 | 2005 | 20130 | 0.150 |
Why?
|
Interferon-beta | 2 | 2009 | 324 | 0.150 |
Why?
|
Equipment Design | 10 | 2006 | 3582 | 0.150 |
Why?
|
Space Perception | 1 | 2000 | 475 | 0.150 |
Why?
|
Premedication | 1 | 1998 | 258 | 0.150 |
Why?
|
Thalidomide | 5 | 2008 | 890 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2007 | 730 | 0.140 |
Why?
|
Blotting, Western | 9 | 2012 | 5181 | 0.140 |
Why?
|
Receptors, Prolactin | 1 | 1996 | 17 | 0.140 |
Why?
|
User-Computer Interface | 3 | 2001 | 1431 | 0.140 |
Why?
|
Survival Analysis | 15 | 2011 | 10252 | 0.140 |
Why?
|
Mice | 36 | 2014 | 81201 | 0.140 |
Why?
|
Image Enhancement | 6 | 2008 | 2921 | 0.140 |
Why?
|
Subarachnoid Hemorrhage | 10 | 1989 | 1018 | 0.140 |
Why?
|
Endothelium, Vascular | 9 | 2005 | 4459 | 0.140 |
Why?
|
Gravity Suits | 2 | 2002 | 12 | 0.140 |
Why?
|
Idoxuridine | 4 | 1998 | 123 | 0.130 |
Why?
|
Pituitary Apoplexy | 2 | 1994 | 30 | 0.130 |
Why?
|
Heterozygote | 3 | 2003 | 2804 | 0.130 |
Why?
|
Trisomy | 2 | 2012 | 266 | 0.130 |
Why?
|
Naloxone | 3 | 1986 | 367 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2000 | 850 | 0.130 |
Why?
|
Tuberous Sclerosis | 3 | 2012 | 1029 | 0.130 |
Why?
|
Encephalitis | 1 | 1999 | 425 | 0.130 |
Why?
|
Survival Rate | 17 | 2008 | 12788 | 0.130 |
Why?
|
Radium | 1 | 1996 | 65 | 0.130 |
Why?
|
Contusions | 2 | 1994 | 81 | 0.130 |
Why?
|
Infant | 24 | 2014 | 35134 | 0.130 |
Why?
|
Cranial Irradiation | 3 | 1996 | 401 | 0.130 |
Why?
|
Technology Assessment, Biomedical | 2 | 2010 | 306 | 0.130 |
Why?
|
Language | 3 | 2004 | 1471 | 0.130 |
Why?
|
Coloring Agents | 1 | 1998 | 566 | 0.130 |
Why?
|
Ribosome Subunits, Small, Eukaryotic | 1 | 2014 | 19 | 0.130 |
Why?
|
Motor Activity | 6 | 2000 | 2715 | 0.130 |
Why?
|
Hypophysectomy | 4 | 1998 | 113 | 0.130 |
Why?
|
Operating Rooms | 2 | 2001 | 817 | 0.130 |
Why?
|
Dosage Compensation, Genetic | 2 | 1995 | 211 | 0.130 |
Why?
|
Transfection | 7 | 2010 | 5895 | 0.130 |
Why?
|
Ventriculoperitoneal Shunt | 3 | 2014 | 194 | 0.130 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2014 | 62 | 0.130 |
Why?
|
Hormones | 2 | 2005 | 889 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 11 | 2010 | 17446 | 0.130 |
Why?
|
Sella Turcica | 2 | 1994 | 119 | 0.130 |
Why?
|
Hemangioma | 1 | 2000 | 738 | 0.130 |
Why?
|
Receptors, Steroid | 1 | 1995 | 155 | 0.130 |
Why?
|
Cluster Analysis | 4 | 2010 | 2715 | 0.120 |
Why?
|
Video Recording | 2 | 1997 | 949 | 0.120 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2009 | 627 | 0.120 |
Why?
|
Quality of Life | 7 | 2010 | 12802 | 0.120 |
Why?
|
Gene Expression Profiling | 8 | 2011 | 9445 | 0.120 |
Why?
|
Pregnancy Complications | 2 | 2007 | 2861 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 1996 | 291 | 0.120 |
Why?
|
Nerve Tissue Proteins | 4 | 2006 | 4463 | 0.120 |
Why?
|
Cell Survival | 9 | 2009 | 5882 | 0.120 |
Why?
|
Practice Guidelines as Topic | 5 | 2005 | 7282 | 0.120 |
Why?
|
Laser Therapy | 4 | 2000 | 1072 | 0.120 |
Why?
|
Cell Growth Processes | 3 | 2010 | 399 | 0.120 |
Why?
|
Case-Control Studies | 23 | 2011 | 21748 | 0.120 |
Why?
|
Urothelium | 2 | 2013 | 277 | 0.120 |
Why?
|
Intraoperative Period | 4 | 2002 | 520 | 0.120 |
Why?
|
Transcription Factors | 4 | 2010 | 12207 | 0.120 |
Why?
|
Genes, Retinoblastoma | 1 | 1994 | 136 | 0.120 |
Why?
|
Hemispherectomy | 1 | 2014 | 44 | 0.120 |
Why?
|
Radiodermatitis | 1 | 1994 | 60 | 0.120 |
Why?
|
Chromosome Aberrations | 4 | 2006 | 1813 | 0.120 |
Why?
|
Bombesin | 1 | 1993 | 34 | 0.120 |
Why?
|
Rats, Inbred Strains | 7 | 1988 | 2186 | 0.120 |
Why?
|
Predictive Value of Tests | 9 | 2014 | 15078 | 0.110 |
Why?
|
Diagnosis, Differential | 13 | 2008 | 12961 | 0.110 |
Why?
|
Sulfonamides | 3 | 2008 | 1940 | 0.110 |
Why?
|
Genes, BRCA1 | 1 | 1997 | 781 | 0.110 |
Why?
|
Tropism | 4 | 2006 | 41 | 0.110 |
Why?
|
Receptors, Dopamine D2 | 1 | 1996 | 475 | 0.110 |
Why?
|
Lactic Acid | 3 | 2009 | 1132 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 3 | 2008 | 351 | 0.110 |
Why?
|
Craniocerebral Trauma | 2 | 1990 | 482 | 0.110 |
Why?
|
Leg | 3 | 1987 | 1116 | 0.110 |
Why?
|
Retrospective Studies | 29 | 2014 | 77460 | 0.110 |
Why?
|
Recurrence | 6 | 2012 | 8340 | 0.110 |
Why?
|
Diagnostic Imaging | 5 | 2011 | 3508 | 0.110 |
Why?
|
Follow-Up Studies | 26 | 2014 | 39052 | 0.110 |
Why?
|
Schools, Medical | 1 | 1999 | 881 | 0.110 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1917 | 0.110 |
Why?
|
Movement Disorders | 3 | 2005 | 446 | 0.110 |
Why?
|
Neoplasm Invasiveness | 8 | 2010 | 3616 | 0.110 |
Why?
|
Africa | 1 | 2014 | 672 | 0.110 |
Why?
|
Brain Chemistry | 3 | 2004 | 982 | 0.110 |
Why?
|
Lumbosacral Region | 2 | 2008 | 310 | 0.110 |
Why?
|
Functional Laterality | 5 | 2014 | 2290 | 0.100 |
Why?
|
Testicular Neoplasms | 2 | 2010 | 806 | 0.100 |
Why?
|
Vitamin A Deficiency | 1 | 1992 | 101 | 0.100 |
Why?
|
Hamartoma | 1 | 1994 | 238 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2000 | 3799 | 0.100 |
Why?
|
Genomics | 2 | 2007 | 5717 | 0.100 |
Why?
|
Karnofsky Performance Status | 2 | 2010 | 173 | 0.100 |
Why?
|
Pituitary Hormones | 3 | 1988 | 183 | 0.100 |
Why?
|
Scalp | 2 | 1998 | 380 | 0.100 |
Why?
|
Nerve Regeneration | 3 | 2008 | 788 | 0.100 |
Why?
|
Disease Models, Animal | 16 | 2011 | 18034 | 0.100 |
Why?
|
Sensitivity and Specificity | 11 | 2008 | 14723 | 0.100 |
Why?
|
Spinal Diseases | 2 | 1994 | 538 | 0.100 |
Why?
|
Matrix Metalloproteinases | 2 | 2007 | 391 | 0.100 |
Why?
|
Visual Perception | 1 | 2000 | 1420 | 0.100 |
Why?
|
Reproducibility of Results | 11 | 2011 | 19905 | 0.100 |
Why?
|
Vitronectin | 2 | 2001 | 44 | 0.100 |
Why?
|
Oculomotor Nerve Diseases | 1 | 1992 | 48 | 0.100 |
Why?
|
Pseudotumor Cerebri | 1 | 1992 | 100 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2010 | 1771 | 0.100 |
Why?
|
Managed Care Programs | 1 | 1997 | 950 | 0.100 |
Why?
|
Proteins | 4 | 2001 | 6100 | 0.100 |
Why?
|
Transplantation, Heterologous | 6 | 2006 | 2383 | 0.100 |
Why?
|
Anticonvulsants | 3 | 2012 | 1916 | 0.100 |
Why?
|
Research | 3 | 2007 | 1999 | 0.100 |
Why?
|
Congresses as Topic | 2 | 2014 | 764 | 0.100 |
Why?
|
Hematoma, Subdural | 2 | 1985 | 126 | 0.100 |
Why?
|
Boston | 8 | 2010 | 9312 | 0.100 |
Why?
|
Pressure | 4 | 1987 | 1203 | 0.100 |
Why?
|
Thallium Radioisotopes | 4 | 1998 | 139 | 0.090 |
Why?
|
Chromosomal Instability | 1 | 2012 | 183 | 0.090 |
Why?
|
Cerebrum | 1 | 2012 | 137 | 0.090 |
Why?
|
Nerve Compression Syndromes | 1 | 1992 | 160 | 0.090 |
Why?
|
HLA-DQ Antigens | 1 | 2010 | 210 | 0.090 |
Why?
|
Polymorphism, Genetic | 4 | 2010 | 4328 | 0.090 |
Why?
|
Craniopharyngioma | 3 | 2007 | 281 | 0.090 |
Why?
|
Polyglycolic Acid | 2 | 2009 | 407 | 0.090 |
Why?
|
Models, Biological | 6 | 2007 | 9584 | 0.090 |
Why?
|
Disease-Free Survival | 8 | 2014 | 6896 | 0.090 |
Why?
|
Nervous System Physiological Phenomena | 1 | 1991 | 117 | 0.090 |
Why?
|
Patient Selection | 5 | 2010 | 4216 | 0.090 |
Why?
|
Neurilemmoma | 2 | 2006 | 547 | 0.090 |
Why?
|
Forecasting | 4 | 2007 | 2951 | 0.090 |
Why?
|
Epidermal Cyst | 1 | 1990 | 62 | 0.090 |
Why?
|
Methacrylates | 1 | 2010 | 107 | 0.090 |
Why?
|
Proportional Hazards Models | 6 | 2013 | 12356 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 7 | 2008 | 8300 | 0.090 |
Why?
|
DNA Repair Enzymes | 2 | 2009 | 349 | 0.090 |
Why?
|
Sphenoid Bone | 2 | 2002 | 172 | 0.090 |
Why?
|
Drug Stability | 1 | 2010 | 291 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2010 | 3326 | 0.090 |
Why?
|
Time Factors | 18 | 2013 | 40075 | 0.090 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 59 | 0.090 |
Why?
|
Reference Values | 5 | 2003 | 4982 | 0.090 |
Why?
|
Electromagnetic Fields | 2 | 2009 | 298 | 0.090 |
Why?
|
Stem Cell Transplantation | 4 | 2009 | 1620 | 0.090 |
Why?
|
Legislation as Topic | 3 | 2005 | 80 | 0.090 |
Why?
|
Pregnancy | 5 | 2007 | 29144 | 0.090 |
Why?
|
Seminoma | 1 | 2010 | 139 | 0.090 |
Why?
|
Art | 1 | 1990 | 65 | 0.090 |
Why?
|
Surgical Mesh | 1 | 2011 | 276 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 645 | 0.080 |
Why?
|
Gene Deletion | 5 | 2012 | 2751 | 0.080 |
Why?
|
Puberty, Precocious | 1 | 1990 | 156 | 0.080 |
Why?
|
Titanium | 1 | 2011 | 494 | 0.080 |
Why?
|
Genetic Markers | 4 | 2003 | 2634 | 0.080 |
Why?
|
Arizona | 5 | 2006 | 108 | 0.080 |
Why?
|
Algorithms | 7 | 2008 | 13882 | 0.080 |
Why?
|
Alternative Splicing | 2 | 2012 | 1117 | 0.080 |
Why?
|
Occupational Exposure | 3 | 2009 | 1793 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 1999 | 7721 | 0.080 |
Why?
|
Suppression, Genetic | 1 | 1989 | 196 | 0.080 |
Why?
|
Epilepsy, Complex Partial | 1 | 2008 | 62 | 0.080 |
Why?
|
Acrylamides | 1 | 2010 | 255 | 0.080 |
Why?
|
Hypersensitivity | 2 | 2011 | 1102 | 0.080 |
Why?
|
Immunoenzyme Techniques | 6 | 1996 | 1799 | 0.080 |
Why?
|
Catalase | 1 | 2008 | 221 | 0.080 |
Why?
|
Radiography | 7 | 2008 | 7023 | 0.080 |
Why?
|
Nerve Tissue | 1 | 1988 | 79 | 0.080 |
Why?
|
Lymph Node Excision | 2 | 2012 | 1262 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2013 | 6539 | 0.080 |
Why?
|
Resource Allocation | 1 | 1990 | 341 | 0.080 |
Why?
|
Nicardipine | 1 | 1988 | 60 | 0.080 |
Why?
|
Neural Inhibition | 1 | 2012 | 602 | 0.080 |
Why?
|
Somatomedins | 1 | 2008 | 192 | 0.080 |
Why?
|
Biopsy, Needle | 3 | 2014 | 1641 | 0.080 |
Why?
|
Ultrasonic Therapy | 1 | 2010 | 235 | 0.080 |
Why?
|
Models, Neurological | 3 | 2003 | 1775 | 0.080 |
Why?
|
Nitrosourea Compounds | 1 | 2007 | 32 | 0.080 |
Why?
|
Tumor Burden | 2 | 2010 | 1915 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2008 | 10943 | 0.080 |
Why?
|
RNA, Neoplasm | 5 | 2007 | 769 | 0.080 |
Why?
|
Foreign Medical Graduates | 2 | 1978 | 79 | 0.080 |
Why?
|
Receptors, Mitogen | 1 | 1987 | 62 | 0.070 |
Why?
|
Gliosarcoma | 2 | 1998 | 114 | 0.070 |
Why?
|
Ependyma | 1 | 1987 | 54 | 0.070 |
Why?
|
Cerebral Decortication | 2 | 1998 | 11 | 0.070 |
Why?
|
Platelet Factor 4 | 1 | 2007 | 129 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 1999 | 1877 | 0.070 |
Why?
|
Receptors, Glutamate | 1 | 2008 | 232 | 0.070 |
Why?
|
Nephrectomy | 1 | 2013 | 1050 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2007 | 55 | 0.070 |
Why?
|
Genes, cdc | 1 | 2007 | 116 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 4 | 2007 | 963 | 0.070 |
Why?
|
Receptors, Opioid, mu | 1 | 2008 | 182 | 0.070 |
Why?
|
Pennsylvania | 5 | 2006 | 613 | 0.070 |
Why?
|
Awards and Prizes | 1 | 2012 | 375 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 2126 | 0.070 |
Why?
|
Olivary Nucleus | 1 | 2008 | 128 | 0.070 |
Why?
|
Statistics as Topic | 4 | 2004 | 2373 | 0.070 |
Why?
|
Stathmin | 1 | 2007 | 71 | 0.070 |
Why?
|
Hair Dyes | 1 | 2006 | 30 | 0.070 |
Why?
|
Base Sequence | 7 | 2008 | 12797 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2010 | 15520 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2010 | 940 | 0.070 |
Why?
|
Receptor, EphA2 | 1 | 2006 | 42 | 0.070 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2007 | 93 | 0.070 |
Why?
|
Microcirculation | 4 | 2004 | 1287 | 0.070 |
Why?
|
International Educational Exchange | 1 | 2007 | 50 | 0.070 |
Why?
|
Etanidazole | 2 | 1998 | 26 | 0.070 |
Why?
|
Hypertrophy | 2 | 2008 | 569 | 0.070 |
Why?
|
DNA Primers | 3 | 2007 | 2891 | 0.070 |
Why?
|
Fibrinolysis | 1 | 1987 | 322 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2007 | 705 | 0.070 |
Why?
|
Glycine | 1 | 2010 | 671 | 0.070 |
Why?
|
Liposomes | 1 | 2010 | 759 | 0.070 |
Why?
|
Neurofibromin 2 | 1 | 2007 | 267 | 0.070 |
Why?
|
Programming Languages | 1 | 2007 | 133 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2000 | 5023 | 0.070 |
Why?
|
Hydrocarbons, Aromatic | 1 | 2006 | 23 | 0.070 |
Why?
|
Ethics, Medical | 3 | 1997 | 792 | 0.070 |
Why?
|
Remission Induction | 3 | 2008 | 2385 | 0.070 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 188 | 0.070 |
Why?
|
Radiotherapy Dosage | 9 | 2005 | 2879 | 0.070 |
Why?
|
Epidermal Growth Factor | 3 | 2010 | 709 | 0.070 |
Why?
|
Porphobilinogen Synthase | 1 | 2005 | 27 | 0.070 |
Why?
|
China | 1 | 2012 | 2245 | 0.070 |
Why?
|
Surgical Wound Infection | 2 | 2011 | 1540 | 0.070 |
Why?
|
Ischemic Attack, Transient | 4 | 1986 | 935 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2008 | 1534 | 0.070 |
Why?
|
Altitude Sickness | 1 | 1986 | 92 | 0.070 |
Why?
|
Extracellular Matrix | 2 | 2006 | 1741 | 0.070 |
Why?
|
Antibodies, Monoclonal | 4 | 2001 | 9274 | 0.070 |
Why?
|
Epilepsy, Partial, Sensory | 1 | 2005 | 1 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 719 | 0.070 |
Why?
|
Neoplasm, Residual | 3 | 2002 | 973 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2008 | 596 | 0.070 |
Why?
|
General Surgery | 1 | 1997 | 1636 | 0.070 |
Why?
|
Stem Cell Niche | 1 | 2009 | 346 | 0.070 |
Why?
|
Subtraction Technique | 2 | 2008 | 525 | 0.070 |
Why?
|
Dysgeusia | 1 | 2005 | 14 | 0.070 |
Why?
|
Vagus Nerve Stimulation | 1 | 2008 | 200 | 0.070 |
Why?
|
Cytosine Deaminase | 4 | 2009 | 68 | 0.070 |
Why?
|
Neurogenesis | 1 | 2012 | 838 | 0.070 |
Why?
|
Spinal Fusion | 2 | 1993 | 1241 | 0.060 |
Why?
|
United States | 16 | 2007 | 69872 | 0.060 |
Why?
|
Household Articles | 1 | 2005 | 24 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 2008 | 18111 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2504 | 0.060 |
Why?
|
Blood Vessels | 2 | 2001 | 1125 | 0.060 |
Why?
|
Luteinizing Hormone | 2 | 1987 | 869 | 0.060 |
Why?
|
Tourniquets | 1 | 1986 | 110 | 0.060 |
Why?
|
Emigration and Immigration | 2 | 1978 | 402 | 0.060 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1463 | 0.060 |
Why?
|
Risk Factors | 16 | 2013 | 72296 | 0.060 |
Why?
|
Prospective Studies | 11 | 2010 | 53290 | 0.060 |
Why?
|
Thrombospondins | 2 | 2008 | 198 | 0.060 |
Why?
|
Genetic Testing | 1 | 1998 | 3444 | 0.060 |
Why?
|
Models, Anatomic | 2 | 1999 | 691 | 0.060 |
Why?
|
Pulmonary Embolism | 4 | 1993 | 2375 | 0.060 |
Why?
|
History, 18th Century | 2 | 2001 | 213 | 0.060 |
Why?
|
Age Distribution | 3 | 2006 | 2902 | 0.060 |
Why?
|
Neuropeptides | 1 | 1991 | 942 | 0.060 |
Why?
|
Basilar Artery | 2 | 1984 | 200 | 0.060 |
Why?
|
Young Adult | 9 | 2012 | 56429 | 0.060 |
Why?
|
Electrolytes | 1 | 1985 | 282 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2001 | 9647 | 0.060 |
Why?
|
Actuarial Analysis | 3 | 1999 | 378 | 0.060 |
Why?
|
Prolactinoma | 2 | 1999 | 113 | 0.060 |
Why?
|
Lipid Metabolism | 2 | 2004 | 1889 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 2 | 1999 | 271 | 0.060 |
Why?
|
Piperazines | 2 | 2009 | 2488 | 0.060 |
Why?
|
Microvessels | 1 | 2009 | 544 | 0.060 |
Why?
|
Microscopy, Fluorescence | 4 | 2009 | 2700 | 0.060 |
Why?
|
Fibroblast Growth Factors | 2 | 2000 | 878 | 0.060 |
Why?
|
Oncogenic Viruses | 1 | 2004 | 42 | 0.060 |
Why?
|
Mathematical Computing | 1 | 2004 | 147 | 0.060 |
Why?
|
Radiology, Interventional | 2 | 1999 | 460 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2007 | 473 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 1988 | 692 | 0.060 |
Why?
|
Confidence Intervals | 3 | 2005 | 2971 | 0.060 |
Why?
|
Sulfasalazine | 1 | 2004 | 79 | 0.060 |
Why?
|
DNA Probes | 2 | 1995 | 560 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2010 | 1182 | 0.060 |
Why?
|
Cells, Cultured | 10 | 2011 | 19233 | 0.060 |
Why?
|
Clone Cells | 3 | 1999 | 1692 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2014 | 11525 | 0.060 |
Why?
|
Vocabulary | 1 | 2005 | 169 | 0.060 |
Why?
|
Software Design | 1 | 2004 | 176 | 0.060 |
Why?
|
Hot Temperature | 1 | 2010 | 1356 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1997 | 769 | 0.060 |
Why?
|
Vestibular Diseases | 1 | 2006 | 217 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 1998 | 3020 | 0.060 |
Why?
|
Cysts | 1 | 1989 | 678 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2007 | 494 | 0.060 |
Why?
|
Stromal Cells | 1 | 2009 | 1355 | 0.060 |
Why?
|
Age Factors | 9 | 2014 | 18373 | 0.060 |
Why?
|
Health Resources | 1 | 1990 | 911 | 0.060 |
Why?
|
Arteriovenous Malformations | 2 | 2005 | 396 | 0.060 |
Why?
|
Morphine | 1 | 2008 | 657 | 0.060 |
Why?
|
Euthanasia, Passive | 2 | 1984 | 66 | 0.060 |
Why?
|
Diffusion | 2 | 2004 | 832 | 0.060 |
Why?
|
Cell Adhesion | 4 | 2006 | 3144 | 0.060 |
Why?
|
Behavioral Symptoms | 1 | 2005 | 175 | 0.060 |
Why?
|
Specialization | 2 | 2007 | 776 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 4751 | 0.060 |
Why?
|
Pituitary Gland, Anterior | 3 | 1994 | 177 | 0.060 |
Why?
|
Risk | 9 | 2006 | 9688 | 0.060 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 667 | 0.060 |
Why?
|
Feasibility Studies | 4 | 2007 | 5077 | 0.060 |
Why?
|
Corneal Neovascularization | 1 | 2005 | 188 | 0.060 |
Why?
|
Genome, Human | 2 | 2006 | 4420 | 0.060 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2003 | 28 | 0.060 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2003 | 36 | 0.060 |
Why?
|
Laminin | 2 | 2006 | 419 | 0.060 |
Why?
|
Methylation | 4 | 2006 | 1106 | 0.060 |
Why?
|
Pyrimidines | 2 | 2009 | 2943 | 0.060 |
Why?
|
Gene Targeting | 1 | 2006 | 880 | 0.050 |
Why?
|
Cell Transplantation | 2 | 2005 | 477 | 0.050 |
Why?
|
Dementia | 2 | 1989 | 2518 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2010 | 10483 | 0.050 |
Why?
|
Astrocytes | 2 | 2000 | 1273 | 0.050 |
Why?
|
Neurologic Examination | 3 | 1997 | 931 | 0.050 |
Why?
|
Creatine | 1 | 2004 | 421 | 0.050 |
Why?
|
Urinary Incontinence | 2 | 1985 | 496 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2006 | 561 | 0.050 |
Why?
|
Judgment | 1 | 2005 | 281 | 0.050 |
Why?
|
Growth Inhibitors | 2 | 2000 | 385 | 0.050 |
Why?
|
Neuroendocrine Tumors | 1 | 2008 | 594 | 0.050 |
Why?
|
Paralysis | 2 | 1997 | 247 | 0.050 |
Why?
|
Integrin alphaVbeta3 | 1 | 2003 | 111 | 0.050 |
Why?
|
Heparin | 3 | 2002 | 1637 | 0.050 |
Why?
|
Neurosciences | 1 | 2007 | 348 | 0.050 |
Why?
|
Bioreactors | 1 | 2003 | 236 | 0.050 |
Why?
|
Abducens Nerve | 1 | 1981 | 28 | 0.050 |
Why?
|
Odds Ratio | 8 | 2010 | 9849 | 0.050 |
Why?
|
Computer Systems | 3 | 1999 | 483 | 0.050 |
Why?
|
Cell Death | 2 | 2001 | 1707 | 0.050 |
Why?
|
Rats, Inbred F344 | 7 | 2000 | 862 | 0.050 |
Why?
|
Dominance, Cerebral | 4 | 1997 | 635 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 190 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 2249 | 0.050 |
Why?
|
Parathyroid Hormone-Related Protein | 2 | 2000 | 331 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2513 | 0.050 |
Why?
|
Artifacts | 2 | 2008 | 1904 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2375 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3508 | 0.050 |
Why?
|
Hyperthermia, Induced | 3 | 2000 | 403 | 0.050 |
Why?
|
Robotics | 1 | 2009 | 899 | 0.050 |
Why?
|
Cavernous Sinus | 2 | 1992 | 125 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2000 | 1660 | 0.050 |
Why?
|
Lead | 1 | 2006 | 852 | 0.050 |
Why?
|
Social Change | 1 | 2002 | 153 | 0.050 |
Why?
|
Receptors, TIE | 1 | 2000 | 10 | 0.050 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2006 | 501 | 0.050 |
Why?
|
Etoposide | 3 | 2010 | 641 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2001 | 6621 | 0.050 |
Why?
|
Psychosurgery | 1 | 2001 | 87 | 0.050 |
Why?
|
Nucleoside Deaminases | 1 | 2000 | 58 | 0.050 |
Why?
|
Suramin | 1 | 2000 | 34 | 0.050 |
Why?
|
Neoplasms | 4 | 2014 | 21696 | 0.050 |
Why?
|
Bandages | 1 | 2002 | 266 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2000 | 42 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2000 | 53 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2000 | 76 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2005 | 1341 | 0.050 |
Why?
|
History, 17th Century | 1 | 2001 | 111 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2000 | 37 | 0.050 |
Why?
|
Safety Management | 1 | 2007 | 783 | 0.050 |
Why?
|
SEER Program | 1 | 2006 | 1507 | 0.050 |
Why?
|
Protons | 4 | 2008 | 1127 | 0.050 |
Why?
|
Electromagnetic Phenomena | 1 | 2002 | 161 | 0.050 |
Why?
|
Tissue Distribution | 3 | 2001 | 2327 | 0.050 |
Why?
|
Endorphins | 3 | 1985 | 75 | 0.050 |
Why?
|
Outpatients | 1 | 2008 | 1487 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2001 | 265 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2007 | 1203 | 0.050 |
Why?
|
England | 1 | 2002 | 522 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2003 | 595 | 0.050 |
Why?
|
Ion Channels | 1 | 1985 | 1056 | 0.050 |
Why?
|
Polylysine | 1 | 2001 | 133 | 0.050 |
Why?
|
Occupations | 1 | 2003 | 517 | 0.050 |
Why?
|
Capsules | 1 | 2001 | 196 | 0.050 |
Why?
|
Membrane Potentials | 4 | 2008 | 1137 | 0.050 |
Why?
|
Peptides, Cyclic | 1 | 2003 | 400 | 0.050 |
Why?
|
Memory | 3 | 2005 | 2174 | 0.050 |
Why?
|
Angiopoietin-1 | 1 | 2000 | 114 | 0.050 |
Why?
|
Animals, Newborn | 2 | 1998 | 2726 | 0.050 |
Why?
|
DNA Methylation | 4 | 2009 | 4285 | 0.050 |
Why?
|
Cyclohexanes | 1 | 2000 | 152 | 0.050 |
Why?
|
Risk Assessment | 5 | 2010 | 23336 | 0.050 |
Why?
|
Enoxaparin | 1 | 2002 | 377 | 0.050 |
Why?
|
Nervous System | 1 | 2003 | 554 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2000 | 53 | 0.050 |
Why?
|
DNA Repair | 1 | 2009 | 2046 | 0.050 |
Why?
|
Transgenes | 1 | 2003 | 1009 | 0.050 |
Why?
|
Transforming Growth Factor alpha | 1 | 2000 | 135 | 0.050 |
Why?
|
Receptor, TIE-2 | 1 | 2000 | 178 | 0.050 |
Why?
|
Gonadal Steroid Hormones | 1 | 2004 | 711 | 0.040 |
Why?
|
Military Medicine | 1 | 2002 | 176 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2008 | 1181 | 0.040 |
Why?
|
Peroxisomes | 1 | 2000 | 58 | 0.040 |
Why?
|
Logistic Models | 6 | 2011 | 13409 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5856 | 0.040 |
Why?
|
Culture Media | 1 | 2001 | 909 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2000 | 172 | 0.040 |
Why?
|
Sesquiterpenes | 1 | 2000 | 177 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1170 | 0.040 |
Why?
|
Intracranial Aneurysm | 2 | 1986 | 1197 | 0.040 |
Why?
|
Retinoids | 1 | 2000 | 101 | 0.040 |
Why?
|
Pilot Projects | 4 | 2008 | 8319 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1423 | 0.040 |
Why?
|
Microscopy, Electron | 6 | 1998 | 2646 | 0.040 |
Why?
|
Ganglioneuroma | 1 | 1999 | 57 | 0.040 |
Why?
|
Self-Assessment | 1 | 2001 | 390 | 0.040 |
Why?
|
Pinealoma | 1 | 1999 | 54 | 0.040 |
Why?
|
Euthanasia | 1 | 1979 | 51 | 0.040 |
Why?
|
Microwaves | 1 | 2001 | 191 | 0.040 |
Why?
|
Germany | 1 | 2001 | 862 | 0.040 |
Why?
|
Alginates | 1 | 2001 | 252 | 0.040 |
Why?
|
Alzheimer Disease | 3 | 2002 | 8038 | 0.040 |
Why?
|
Pituitary Function Tests | 1 | 1998 | 27 | 0.040 |
Why?
|
Monitoring, Physiologic | 3 | 1996 | 1739 | 0.040 |
Why?
|
Pneumocephalus | 1 | 1979 | 46 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2887 | 0.040 |
Why?
|
Endocrine System Diseases | 2 | 1998 | 248 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2011 | 13991 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 4 | 2006 | 1375 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2005 | 1405 | 0.040 |
Why?
|
Tissue Survival | 1 | 1998 | 118 | 0.040 |
Why?
|
Pain, Intractable | 1 | 1979 | 130 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 323 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2000 | 335 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2000 | 351 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2008 | 4253 | 0.040 |
Why?
|
Seasons | 1 | 2004 | 1493 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2000 | 320 | 0.040 |
Why?
|
Cisplatin | 2 | 2010 | 1662 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2000 | 3480 | 0.040 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 112 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6489 | 0.040 |
Why?
|
Fluorescence | 1 | 2001 | 751 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2004 | 4554 | 0.040 |
Why?
|
Medical Errors | 1 | 2007 | 1297 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 1999 | 175 | 0.040 |
Why?
|
Protein Subunits | 2 | 2014 | 959 | 0.040 |
Why?
|
Water | 1 | 2004 | 1395 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1547 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3056 | 0.040 |
Why?
|
Meningomyelocele | 1 | 1979 | 165 | 0.040 |
Why?
|
Hemodynamics | 2 | 1987 | 4196 | 0.040 |
Why?
|
Clinical Trials as Topic | 7 | 2007 | 7914 | 0.040 |
Why?
|
Spinal Cord Diseases | 2 | 1978 | 298 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2002 | 924 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2000 | 612 | 0.040 |
Why?
|
Arachnoid Cysts | 1 | 1998 | 59 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2011 | 712 | 0.040 |
Why?
|
Clinical Protocols | 2 | 2008 | 1461 | 0.040 |
Why?
|
Hemiplegia | 2 | 1995 | 135 | 0.040 |
Why?
|
Capillaries | 1 | 2001 | 773 | 0.040 |
Why?
|
Telephone | 1 | 2001 | 617 | 0.040 |
Why?
|
Radiotherapy, Conformal | 1 | 2001 | 548 | 0.040 |
Why?
|
Confusion | 1 | 1999 | 275 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2000 | 546 | 0.040 |
Why?
|
Gatekeeping | 1 | 1997 | 45 | 0.040 |
Why?
|
Rabbits | 5 | 1992 | 4894 | 0.040 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 2 | 2008 | 85 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2001 | 2050 | 0.040 |
Why?
|
Oligopeptides | 1 | 2003 | 1189 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3084 | 0.040 |
Why?
|
Spinal Cord Neoplasms | 1 | 1979 | 281 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2000 | 664 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2000 | 476 | 0.040 |
Why?
|
Tokyo | 1 | 1996 | 22 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 2505 | 0.040 |
Why?
|
Cricetinae | 1 | 2001 | 2475 | 0.040 |
Why?
|
Spin Labels | 2 | 2008 | 332 | 0.040 |
Why?
|
Rats, Inbred Lew | 1 | 1998 | 1162 | 0.040 |
Why?
|
Jurisprudence | 1 | 1997 | 110 | 0.040 |
Why?
|
Endopeptidases | 1 | 2000 | 772 | 0.040 |
Why?
|
Cerebral Hemorrhage | 2 | 2007 | 2647 | 0.040 |
Why?
|
Inpatients | 1 | 2008 | 2518 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 1999 | 659 | 0.040 |
Why?
|
Dopamine | 3 | 1990 | 1591 | 0.040 |
Why?
|
Necrosis | 4 | 2000 | 1643 | 0.040 |
Why?
|
Phosphotyrosine | 1 | 1997 | 457 | 0.040 |
Why?
|
Cognition | 3 | 2005 | 6770 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2002 | 735 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2000 | 417 | 0.030 |
Why?
|
Fibronectins | 1 | 2000 | 726 | 0.030 |
Why?
|
Decision Making | 2 | 2008 | 3888 | 0.030 |
Why?
|
Cell Line | 7 | 2009 | 16000 | 0.030 |
Why?
|
Economics | 1 | 1997 | 146 | 0.030 |
Why?
|
Incidence | 5 | 2005 | 20952 | 0.030 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12244 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2009 | 3486 | 0.030 |
Why?
|
Antibodies, Neoplasm | 1 | 1997 | 286 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2001 | 970 | 0.030 |
Why?
|
Bromocriptine | 3 | 1999 | 111 | 0.030 |
Why?
|
Promegestone | 1 | 1995 | 9 | 0.030 |
Why?
|
Tyrosine Transaminase | 1 | 1995 | 11 | 0.030 |
Why?
|
Phosphoglycerate Kinase | 1 | 1995 | 68 | 0.030 |
Why?
|
Utah | 2 | 2006 | 126 | 0.030 |
Why?
|
Progesterone Congeners | 1 | 1995 | 42 | 0.030 |
Why?
|
Nervous System Diseases | 2 | 2002 | 1622 | 0.030 |
Why?
|
Pediatrics | 1 | 1991 | 3475 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2004 | 1469 | 0.030 |
Why?
|
Learning | 1 | 1985 | 1711 | 0.030 |
Why?
|
Antigens, Neoplasm | 2 | 2006 | 1988 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1998 | 358 | 0.030 |
Why?
|
Acromegaly | 1 | 1998 | 347 | 0.030 |
Why?
|
Hospital Charges | 1 | 1997 | 362 | 0.030 |
Why?
|
NF-kappa B | 1 | 2004 | 2499 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1995 | 222 | 0.030 |
Why?
|
Mannitol | 1 | 1996 | 181 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 1997 | 328 | 0.030 |
Why?
|
Paresthesia | 1 | 1996 | 161 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2001 | 1115 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 871 | 0.030 |
Why?
|
Pharyngeal Diseases | 1 | 1996 | 133 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 619 | 0.030 |
Why?
|
Peptides | 2 | 1990 | 4410 | 0.030 |
Why?
|
Surgical Flaps | 2 | 1994 | 1640 | 0.030 |
Why?
|
Hypothalamus | 3 | 1990 | 1063 | 0.030 |
Why?
|
Organotechnetium Compounds | 2 | 1994 | 137 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2006 | 2760 | 0.030 |
Why?
|
Hindlimb | 2 | 1988 | 504 | 0.030 |
Why?
|
Length of Stay | 1 | 2008 | 6311 | 0.030 |
Why?
|
Oncogene Proteins v-fos | 1 | 1994 | 14 | 0.030 |
Why?
|
Environmental Exposure | 2 | 2006 | 4232 | 0.030 |
Why?
|
Hypnotics and Sedatives | 2 | 2000 | 1162 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2006 | 3476 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 1999 | 577 | 0.030 |
Why?
|
Thymidine Kinase | 1 | 1995 | 290 | 0.030 |
Why?
|
Alleles | 2 | 1998 | 6933 | 0.030 |
Why?
|
Sex Factors | 5 | 2014 | 10400 | 0.030 |
Why?
|
Swine | 2 | 2005 | 5918 | 0.030 |
Why?
|
Cattle | 1 | 2001 | 3922 | 0.030 |
Why?
|
Patient Advocacy | 1 | 1997 | 353 | 0.030 |
Why?
|
Actins | 2 | 2000 | 2121 | 0.030 |
Why?
|
Eosinophils | 1 | 1999 | 955 | 0.030 |
Why?
|
Peripheral Nerves | 2 | 2008 | 466 | 0.030 |
Why?
|
Chemotaxis | 2 | 2009 | 607 | 0.030 |
Why?
|
Interview, Psychological | 1 | 1998 | 812 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 1996 | 2765 | 0.030 |
Why?
|
Computer Simulation | 3 | 2011 | 6194 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2006 | 25628 | 0.030 |
Why?
|
Electric Stimulation | 3 | 1995 | 1767 | 0.030 |
Why?
|
Pituitary Irradiation | 1 | 1994 | 17 | 0.030 |
Why?
|
Li-Fraumeni Syndrome | 1 | 1995 | 114 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6364 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 2938 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2014 | 166 | 0.030 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1994 | 54 | 0.030 |
Why?
|
Developing Countries | 1 | 2007 | 2815 | 0.030 |
Why?
|
Culture Media, Conditioned | 2 | 2006 | 537 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2000 | 4185 | 0.030 |
Why?
|
British Columbia | 1 | 2014 | 244 | 0.030 |
Why?
|
Molecular Probes | 1 | 1996 | 316 | 0.030 |
Why?
|
Genes, p16 | 2 | 2007 | 157 | 0.030 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2011 | 496 | 0.030 |
Why?
|
Cerebral Ventriculography | 2 | 1985 | 44 | 0.030 |
Why?
|
Cats | 3 | 1985 | 1000 | 0.030 |
Why?
|
Pneumoencephalography | 2 | 1984 | 22 | 0.030 |
Why?
|
Radionuclide Imaging | 5 | 1996 | 2031 | 0.030 |
Why?
|
Autoimmune Diseases | 2 | 2004 | 2134 | 0.030 |
Why?
|
Medical Records | 2 | 2010 | 1413 | 0.030 |
Why?
|
Glycosylation | 1 | 1997 | 1128 | 0.030 |
Why?
|
Chloramphenicol | 1 | 1973 | 75 | 0.030 |
Why?
|
Oximes | 2 | 1994 | 311 | 0.030 |
Why?
|
Nafcillin | 1 | 1973 | 25 | 0.030 |
Why?
|
PUVA Therapy | 1 | 1993 | 98 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 1504 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1994 | 251 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1993 | 326 | 0.030 |
Why?
|
Propofol | 1 | 2000 | 629 | 0.030 |
Why?
|
Motor Skills | 2 | 1986 | 522 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2009 | 187 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2000 | 985 | 0.030 |
Why?
|
Molecular Biology | 1 | 1997 | 596 | 0.030 |
Why?
|
Massachusetts | 4 | 2006 | 8662 | 0.030 |
Why?
|
Diethylstilbestrol | 2 | 1990 | 93 | 0.030 |
Why?
|
Laminectomy | 1 | 1994 | 234 | 0.030 |
Why?
|
Methicillin | 1 | 1973 | 59 | 0.030 |
Why?
|
Mutagenesis | 1 | 1997 | 1264 | 0.030 |
Why?
|
Linear Models | 3 | 2006 | 5953 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2000 | 1800 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1996 | 798 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1993 | 177 | 0.030 |
Why?
|
Myelography | 2 | 1985 | 69 | 0.030 |
Why?
|
Phantoms, Imaging | 2 | 2000 | 2480 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 3873 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2002 | 2158 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2004 | 2737 | 0.030 |
Why?
|
Galactorrhea | 1 | 1992 | 24 | 0.030 |
Why?
|
Ligands | 1 | 2000 | 3282 | 0.030 |
Why?
|
Vasopressins | 2 | 1985 | 370 | 0.030 |
Why?
|
Cell Lineage | 1 | 2001 | 2504 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 1997 | 794 | 0.030 |
Why?
|
Brain Abscess | 1 | 1973 | 118 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1992 | 313 | 0.030 |
Why?
|
Anesthesia | 2 | 2002 | 1561 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2001 | 2419 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2001 | 1736 | 0.030 |
Why?
|
Ki-67 Antigen | 2 | 2005 | 644 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5172 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1995 | 1144 | 0.030 |
Why?
|
Arteries | 1 | 1997 | 1119 | 0.030 |
Why?
|
Blood-Brain Barrier | 2 | 1992 | 1019 | 0.030 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 102 | 0.030 |
Why?
|
Genotype | 4 | 2010 | 12952 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 12073 | 0.030 |
Why?
|
Histocytochemistry | 3 | 1988 | 719 | 0.030 |
Why?
|
Telomere | 1 | 1998 | 910 | 0.030 |
Why?
|
Genes, p53 | 2 | 2007 | 755 | 0.030 |
Why?
|
Cohort Studies | 2 | 2005 | 40559 | 0.030 |
Why?
|
Mast Cells | 1 | 1999 | 1544 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1996 | 669 | 0.030 |
Why?
|
Analysis of Variance | 4 | 2005 | 6366 | 0.030 |
Why?
|
Elasticity | 2 | 2004 | 657 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2014 | 434 | 0.030 |
Why?
|
Random Allocation | 2 | 2005 | 2428 | 0.030 |
Why?
|
Spinal Neoplasms | 2 | 1994 | 760 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2924 | 0.020 |
Why?
|
Laser Coagulation | 1 | 1993 | 326 | 0.020 |
Why?
|
Oncogenes | 1 | 1997 | 1265 | 0.020 |
Why?
|
Subdural Space | 3 | 1995 | 32 | 0.020 |
Why?
|
Technetium Tc 99m Exametazime | 3 | 1998 | 68 | 0.020 |
Why?
|
Arginine | 2 | 1994 | 944 | 0.020 |
Why?
|
Methotrexate | 1 | 1998 | 1728 | 0.020 |
Why?
|
Cerebral Arteries | 2 | 1984 | 494 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2001 | 3424 | 0.020 |
Why?
|
Menstruation Disturbances | 1 | 1992 | 148 | 0.020 |
Why?
|
Attitude to Health | 1 | 2000 | 2052 | 0.020 |
Why?
|
Ureteral Neoplasms | 1 | 2012 | 111 | 0.020 |
Why?
|
Cephalometry | 1 | 1992 | 382 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2005 | 4043 | 0.020 |
Why?
|
Electrodes, Implanted | 3 | 2005 | 824 | 0.020 |
Why?
|
Interviews as Topic | 1 | 1998 | 2539 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5263 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1995 | 1401 | 0.020 |
Why?
|
Lymphocytes | 2 | 1997 | 2617 | 0.020 |
Why?
|
Torticollis | 1 | 1991 | 66 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2008 | 5867 | 0.020 |
Why?
|
Penicillins | 1 | 1973 | 380 | 0.020 |
Why?
|
Chromosome Mapping | 4 | 2007 | 4740 | 0.020 |
Why?
|
Amenorrhea | 1 | 1994 | 485 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 1984 | 3841 | 0.020 |
Why?
|
Receptors, GABA | 1 | 2012 | 287 | 0.020 |
Why?
|
Cyclophosphamide | 3 | 2007 | 2242 | 0.020 |
Why?
|
Fatal Outcome | 2 | 2008 | 1851 | 0.020 |
Why?
|
Pituitary Gland, Posterior | 2 | 1990 | 43 | 0.020 |
Why?
|
Immunotherapy | 2 | 2003 | 4446 | 0.020 |
Why?
|
Tissue Donors | 2 | 1991 | 2241 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 1994 | 748 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1536 | 0.020 |
Why?
|
Registries | 1 | 2005 | 8091 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2585 | 0.020 |
Why?
|
Diuretics, Osmotic | 2 | 1979 | 37 | 0.020 |
Why?
|
Affect | 1 | 1998 | 1475 | 0.020 |
Why?
|
Caspase 3 | 2 | 2004 | 758 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4933 | 0.020 |
Why?
|
Orthopedic Fixation Devices | 1 | 1989 | 75 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1434 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2011 | 321 | 0.020 |
Why?
|
Meningism | 1 | 1989 | 1 | 0.020 |
Why?
|
Benzamides | 2 | 2009 | 1379 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 733 | 0.020 |
Why?
|
Dextrans | 1 | 2011 | 595 | 0.020 |
Why?
|
Technetium Compounds | 1 | 1989 | 15 | 0.020 |
Why?
|
Karyotyping | 2 | 2001 | 1243 | 0.020 |
Why?
|
Bleomycin | 1 | 2010 | 512 | 0.020 |
Why?
|
Arteriovenous Fistula | 1 | 1973 | 315 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3771 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2012 | 964 | 0.020 |
Why?
|
Heart Diseases | 1 | 2002 | 2789 | 0.020 |
Why?
|
Osteomyelitis | 1 | 1993 | 402 | 0.020 |
Why?
|
Melanoma | 2 | 2005 | 5511 | 0.020 |
Why?
|
Symporters | 1 | 2012 | 361 | 0.020 |
Why?
|
Inositol | 1 | 2010 | 218 | 0.020 |
Why?
|
Caspases | 2 | 2004 | 928 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1990 | 375 | 0.020 |
Why?
|
Sarcoidosis | 2 | 1989 | 506 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 2 | 2007 | 1142 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 1994 | 1066 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2002 | 12025 | 0.020 |
Why?
|
Regression Analysis | 2 | 2010 | 6459 | 0.020 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1989 | 307 | 0.020 |
Why?
|
Hemianopsia | 1 | 1990 | 122 | 0.020 |
Why?
|
Signal Transduction | 3 | 2005 | 23404 | 0.020 |
Why?
|
France | 1 | 1990 | 517 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2008 | 212 | 0.020 |
Why?
|
Orchiectomy | 1 | 2010 | 474 | 0.020 |
Why?
|
Data Mining | 1 | 2013 | 537 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 206 | 0.020 |
Why?
|
Cyclin H | 1 | 2007 | 5 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 2 | 1987 | 744 | 0.020 |
Why?
|
Personal Autonomy | 1 | 1990 | 298 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1989 | 437 | 0.020 |
Why?
|
Nausea | 1 | 1991 | 674 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2065 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2008 | 170 | 0.020 |
Why?
|
Treatment Failure | 3 | 2003 | 2618 | 0.020 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2008 | 179 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2006 | 3130 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1995 | 1171 | 0.020 |
Why?
|
von Hippel-Lindau Disease | 1 | 1989 | 152 | 0.020 |
Why?
|
Cyclin D | 1 | 2007 | 72 | 0.020 |
Why?
|
Nitric Oxide | 2 | 1994 | 2132 | 0.020 |
Why?
|
Gastrointestinal Transit | 1 | 2008 | 96 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 6994 | 0.020 |
Why?
|
Hypesthesia | 1 | 2008 | 109 | 0.020 |
Why?
|
3T3 Cells | 2 | 2000 | 1101 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2014 | 15535 | 0.020 |
Why?
|
Age of Onset | 1 | 1994 | 3270 | 0.020 |
Why?
|
Pyrazoles | 2 | 2008 | 1972 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 2 | 1987 | 648 | 0.020 |
Why?
|
Skull | 1 | 2011 | 814 | 0.020 |
Why?
|
Caspase 8 | 1 | 2007 | 195 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 280 | 0.020 |
Why?
|
Aphasia, Wernicke | 1 | 1986 | 19 | 0.020 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 1987 | 80 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1993 | 976 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2007 | 73 | 0.020 |
Why?
|
Probability | 2 | 2003 | 2506 | 0.020 |
Why?
|
Eye Neoplasms | 1 | 1989 | 312 | 0.020 |
Why?
|
Beauty Culture | 1 | 2006 | 41 | 0.020 |
Why?
|
Aphasia, Broca | 1 | 1986 | 50 | 0.020 |
Why?
|
Diabetes Insipidus | 1 | 1987 | 151 | 0.020 |
Why?
|
Longevity | 1 | 2014 | 1071 | 0.020 |
Why?
|
Injections, Intralesional | 2 | 1998 | 276 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 2007 | 156 | 0.020 |
Why?
|
Complement System Proteins | 1 | 1989 | 795 | 0.020 |
Why?
|
Acclimatization | 1 | 1986 | 103 | 0.020 |
Why?
|
Drug Resistance | 1 | 1992 | 1608 | 0.020 |
Why?
|
Hematopoiesis | 1 | 1996 | 2073 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 365 | 0.020 |
Why?
|
History, Ancient | 1 | 1986 | 212 | 0.020 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2006 | 46 | 0.020 |
Why?
|
Substantia Nigra | 1 | 1988 | 353 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 1973 | 879 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2010 | 492 | 0.020 |
Why?
|
Retinoblastoma | 1 | 1989 | 317 | 0.020 |
Why?
|
Retroperitoneal Space | 1 | 2006 | 176 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2006 | 91 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1987 | 265 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2006 | 224 | 0.020 |
Why?
|
Cerebral Angiography | 4 | 1985 | 1285 | 0.020 |
Why?
|
Paraplegia | 1 | 1986 | 169 | 0.020 |
Why?
|
Ophthalmoplegia | 1 | 1987 | 166 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 1999 | 4666 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 1990 | 749 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 2006 | 199 | 0.020 |
Why?
|
Ear Canal | 1 | 2006 | 146 | 0.020 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 1985 | 25 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2007 | 220 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1995 | 2969 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1989 | 1369 | 0.020 |
Why?
|
Government Regulation | 1 | 1990 | 522 | 0.020 |
Why?
|
Anions | 1 | 1985 | 133 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1252 | 0.020 |
Why?
|
Ataxia | 1 | 2008 | 304 | 0.020 |
Why?
|
Memory Disorders | 2 | 1985 | 1186 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2008 | 449 | 0.020 |
Why?
|
Mental Disorders | 1 | 2005 | 6598 | 0.020 |
Why?
|
Absorption | 1 | 1985 | 248 | 0.020 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 1985 | 10 | 0.020 |
Why?
|
Heart Atria | 2 | 1982 | 1356 | 0.020 |
Why?
|
Dog Diseases | 2 | 1983 | 138 | 0.020 |
Why?
|
Mathematics | 1 | 1986 | 728 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 1998 | 3395 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2006 | 122 | 0.020 |
Why?
|
Pathology, Surgical | 1 | 2006 | 155 | 0.020 |
Why?
|
Cefotaxime | 1 | 1984 | 35 | 0.020 |
Why?
|
Guanine | 1 | 2006 | 274 | 0.020 |
Why?
|
Acute Disease | 2 | 1986 | 7147 | 0.020 |
Why?
|
Speech | 2 | 2004 | 541 | 0.020 |
Why?
|
Kaolin | 1 | 1984 | 15 | 0.020 |
Why?
|
Syndrome | 2 | 1994 | 3252 | 0.020 |
Why?
|
Cyclins | 1 | 2007 | 603 | 0.020 |
Why?
|
Brain Stem | 1 | 1990 | 846 | 0.020 |
Why?
|
Biological Factors | 1 | 2006 | 164 | 0.020 |
Why?
|
Comorbidity | 2 | 2013 | 10388 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2005 | 231 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2007 | 381 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1988 | 464 | 0.020 |
Why?
|
Aphasia | 1 | 1986 | 184 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 677 | 0.020 |
Why?
|
Lectins | 1 | 1987 | 513 | 0.020 |
Why?
|
Phlebography | 1 | 1986 | 333 | 0.020 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 257 | 0.020 |
Why?
|
Vasa Vasorum | 1 | 1984 | 26 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2005 | 433 | 0.020 |
Why?
|
Macrophages | 1 | 1999 | 5660 | 0.020 |
Why?
|
Educational Status | 2 | 2003 | 2540 | 0.020 |
Why?
|
Brain Stem Neoplasms | 1 | 2006 | 204 | 0.020 |
Why?
|
Melatonin | 1 | 1990 | 721 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 1990 | 1276 | 0.020 |
Why?
|
Software Validation | 1 | 2004 | 59 | 0.020 |
Why?
|
Reflex, Pupillary | 1 | 1984 | 61 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1985 | 301 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 380 | 0.010 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2004 | 141 | 0.010 |
Why?
|
Metabolome | 1 | 2011 | 895 | 0.010 |
Why?
|
DNA | 1 | 1998 | 7294 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1865 | 0.010 |
Why?
|
Histological Techniques | 1 | 2004 | 198 | 0.010 |
Why?
|
Patient Discharge | 1 | 1997 | 3318 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 1995 | 4805 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1991 | 1151 | 0.010 |
Why?
|
Referral and Consultation | 1 | 1997 | 3531 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 1988 | 1206 | 0.010 |
Why?
|
Neurofibromatosis 2 | 1 | 2007 | 380 | 0.010 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2004 | 205 | 0.010 |
Why?
|
Body Weights and Measures | 1 | 2004 | 211 | 0.010 |
Why?
|
Blinking | 1 | 1984 | 138 | 0.010 |
Why?
|
Aging | 2 | 1996 | 8664 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 644 | 0.010 |
Why?
|
Vision Disorders | 2 | 1990 | 1058 | 0.010 |
Why?
|
Extracellular Space | 1 | 1985 | 595 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1986 | 1681 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1997 | 3229 | 0.010 |
Why?
|
Income | 2 | 2003 | 1913 | 0.010 |
Why?
|
Inflammation | 2 | 2002 | 10637 | 0.010 |
Why?
|
Neurofibromatosis 1 | 1 | 1989 | 570 | 0.010 |
Why?
|
Telencephalon | 1 | 2004 | 142 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2000 | 7882 | 0.010 |
Why?
|
Aminophylline | 1 | 1983 | 40 | 0.010 |
Why?
|
Papaverine | 1 | 1983 | 46 | 0.010 |
Why?
|
Multigene Family | 1 | 2006 | 1102 | 0.010 |
Why?
|
Autoradiography | 2 | 1997 | 745 | 0.010 |
Why?
|
Iron | 1 | 2011 | 1774 | 0.010 |
Why?
|
Neurophysins | 1 | 1982 | 14 | 0.010 |
Why?
|
Particle Size | 1 | 2007 | 1642 | 0.010 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1982 | 41 | 0.010 |
Why?
|
Occipital Lobe | 1 | 1985 | 379 | 0.010 |
Why?
|
Meningitis | 1 | 1984 | 216 | 0.010 |
Why?
|
Intercellular Junctions | 2 | 1984 | 203 | 0.010 |
Why?
|
Electromyography | 1 | 2008 | 1379 | 0.010 |
Why?
|
Glutathione S-Transferase pi | 1 | 2003 | 97 | 0.010 |
Why?
|
Food Industry | 1 | 2003 | 68 | 0.010 |
Why?
|
Contraceptives, Oral | 1 | 2005 | 564 | 0.010 |
Why?
|
Indium | 1 | 1982 | 46 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 547 | 0.010 |
Why?
|
Menarche | 1 | 2005 | 516 | 0.010 |
Why?
|
Pedigree | 2 | 2003 | 4642 | 0.010 |
Why?
|
Cerebellum | 2 | 2000 | 1488 | 0.010 |
Why?
|
Graft Survival | 2 | 1994 | 3737 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1828 | 0.010 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 1982 | 69 | 0.010 |
Why?
|
Hematoma | 1 | 2007 | 758 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 552 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2008 | 814 | 0.010 |
Why?
|
Peritoneal Cavity | 1 | 1982 | 148 | 0.010 |
Why?
|
Choroid Plexus | 1 | 1984 | 231 | 0.010 |
Why?
|
Hypopituitarism | 2 | 1998 | 254 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1988 | 1221 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 1982 | 183 | 0.010 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2001 | 90 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1999 | 10183 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2007 | 789 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 1351 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1284 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1970 | 0.010 |
Why?
|
Marital Status | 1 | 2003 | 437 | 0.010 |
Why?
|
Exons | 1 | 2007 | 2439 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2890 | 0.010 |
Why?
|
Central Nervous System | 1 | 1989 | 1357 | 0.010 |
Why?
|
Oxytocin | 1 | 1985 | 394 | 0.010 |
Why?
|
Semantics | 1 | 2005 | 585 | 0.010 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2001 | 125 | 0.010 |
Why?
|
Respiration | 2 | 1985 | 1653 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1981 | 112 | 0.010 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2002 | 215 | 0.010 |
Why?
|
Hippocampus | 2 | 1996 | 3675 | 0.010 |
Why?
|
Cyclin E | 1 | 2001 | 172 | 0.010 |
Why?
|
Haplotypes | 1 | 2007 | 2779 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2649 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2005 | 547 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 2 | 1979 | 1856 | 0.010 |
Why?
|
Parturition | 1 | 2004 | 441 | 0.010 |
Why?
|
Radioisotopes | 1 | 1982 | 500 | 0.010 |
Why?
|
Sphenoid Sinus | 1 | 2001 | 99 | 0.010 |
Why?
|
Prostaglandin D2 | 1 | 2000 | 122 | 0.010 |
Why?
|
Tomography | 1 | 1982 | 390 | 0.010 |
Why?
|
Protein Kinases | 1 | 2007 | 1640 | 0.010 |
Why?
|
Angiography | 1 | 1986 | 1639 | 0.010 |
Why?
|
Atrophy | 1 | 1985 | 1584 | 0.010 |
Why?
|
Genes, erbB-1 | 1 | 2000 | 161 | 0.010 |
Why?
|
Mechlorethamine | 1 | 1979 | 136 | 0.010 |
Why?
|
Anura | 1 | 1979 | 86 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2008 | 1881 | 0.010 |
Why?
|
Withholding Treatment | 1 | 1984 | 599 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 2000 | 6386 | 0.010 |
Why?
|
Permeability | 1 | 1982 | 738 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2000 | 242 | 0.010 |
Why?
|
Dexamethasone | 2 | 1994 | 1951 | 0.010 |
Why?
|
Kidney | 1 | 1995 | 7184 | 0.010 |
Why?
|
Religion | 1 | 2003 | 356 | 0.010 |
Why?
|
Phosphorylcholine | 1 | 2000 | 162 | 0.010 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 1995 | 243 | 0.010 |
Why?
|
Synaptophysin | 1 | 1999 | 141 | 0.010 |
Why?
|
Radio Waves | 1 | 2001 | 251 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2001 | 463 | 0.010 |
Why?
|
Desmosomes | 1 | 1979 | 73 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2001 | 431 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 1995 | 2569 | 0.010 |
Why?
|
Hormone Antagonists | 1 | 1999 | 108 | 0.010 |
Why?
|
Lactates | 1 | 2000 | 432 | 0.010 |
Why?
|
Gliosis | 1 | 2000 | 245 | 0.010 |
Why?
|
Anisotropy | 1 | 2002 | 1265 | 0.010 |
Why?
|
Echoencephalography | 1 | 1979 | 135 | 0.010 |
Why?
|
Micropore Filters | 1 | 1978 | 23 | 0.010 |
Why?
|
Internationality | 1 | 2005 | 1002 | 0.010 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2000 | 315 | 0.010 |
Why?
|
Cryotherapy | 1 | 2000 | 155 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 2000 | 567 | 0.010 |
Why?
|
Haplorhini | 1 | 1979 | 552 | 0.010 |
Why?
|
Dogs | 4 | 1985 | 3912 | 0.010 |
Why?
|
Data Display | 1 | 1999 | 182 | 0.010 |
Why?
|
Chemokines | 1 | 2003 | 970 | 0.010 |
Why?
|
Electrophysiology | 1 | 1982 | 1308 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1990 | 2624 | 0.010 |
Why?
|
Carboplatin | 1 | 2001 | 801 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1988 | 1378 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2297 | 0.010 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1997 | 60 | 0.010 |
Why?
|
Cytokines | 2 | 2009 | 7323 | 0.010 |
Why?
|
Biomedical Engineering | 1 | 2000 | 296 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1983 | 793 | 0.010 |
Why?
|
Radiopharmaceuticals | 2 | 1998 | 2645 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2005 | 2026 | 0.010 |
Why?
|
Reaction Time | 1 | 2005 | 2098 | 0.010 |
Why?
|
Culture Techniques | 1 | 1978 | 554 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 1993 | 13104 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7730 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1998 | 228 | 0.010 |
Why?
|
Mutation | 3 | 2010 | 29786 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2001 | 539 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1655 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2001 | 671 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2926 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1985 | 1504 | 0.010 |
Why?
|
Movement | 1 | 2004 | 1471 | 0.010 |
Why?
|
Femoral Artery | 1 | 1982 | 845 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2011 | 2213 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2001 | 705 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 1999 | 318 | 0.010 |
Why?
|
Cauda Equina | 1 | 1977 | 42 | 0.010 |
Why?
|
Long-Term Care | 1 | 2001 | 607 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1997 | 219 | 0.010 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 1997 | 49 | 0.010 |
Why?
|
Menopause | 1 | 2005 | 1626 | 0.010 |
Why?
|
Radiation Injuries | 2 | 1995 | 1180 | 0.010 |
Why?
|
Fentanyl | 1 | 2000 | 409 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2006 | 1903 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 294 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1978 | 219 | 0.010 |
Why?
|
Endoscopes | 1 | 1997 | 175 | 0.010 |
Why?
|
DNA Damage | 1 | 2006 | 2432 | 0.010 |
Why?
|
Injections, Spinal | 1 | 1997 | 303 | 0.010 |
Why?
|
Growth Hormone | 2 | 1990 | 705 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 1984 | 896 | 0.010 |
Why?
|
Testosterone | 1 | 1987 | 2419 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5974 | 0.010 |
Why?
|
Hospices | 1 | 1979 | 265 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1984 | 1401 | 0.010 |
Why?
|
Patients | 1 | 2002 | 900 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4222 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 2716 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 1979 | 435 | 0.010 |
Why?
|
Telemetry | 1 | 1997 | 207 | 0.010 |
Why?
|
Ethmoid Sinusitis | 1 | 1995 | 25 | 0.010 |
Why?
|
Edema | 1 | 1979 | 789 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1997 | 1095 | 0.010 |
Why?
|
Carotid Arteries | 2 | 1986 | 950 | 0.010 |
Why?
|
Cost Control | 1 | 1997 | 624 | 0.010 |
Why?
|
Constipation | 1 | 2000 | 546 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4262 | 0.010 |
Why?
|
Maxillary Sinusitis | 1 | 1995 | 39 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2716 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2002 | 1359 | 0.010 |
Why?
|
Observer Variation | 1 | 2001 | 2593 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1995 | 172 | 0.010 |
Why?
|
Hematocrit | 1 | 1996 | 636 | 0.010 |
Why?
|
Gait | 1 | 1980 | 793 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 1979 | 752 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2282 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2000 | 685 | 0.010 |
Why?
|
omega-N-Methylarginine | 1 | 1994 | 111 | 0.010 |
Why?
|
Rats, Nude | 1 | 1994 | 105 | 0.010 |
Why?
|
HeLa Cells | 1 | 2000 | 3130 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 1995 | 145 | 0.010 |
Why?
|
Computer Graphics | 1 | 1996 | 361 | 0.010 |
Why?
|
Pharynx | 1 | 1996 | 413 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2000 | 1275 | 0.010 |
Why?
|
Psychotropic Drugs | 1 | 1979 | 894 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1994 | 254 | 0.010 |
Why?
|
Penicillin Resistance | 1 | 1973 | 84 | 0.010 |
Why?
|
Research Design | 2 | 2004 | 5984 | 0.010 |
Why?
|
Cell Communication | 1 | 1980 | 1621 | 0.010 |
Why?
|
Family | 1 | 1984 | 3147 | 0.010 |
Why?
|
Particle Accelerators | 1 | 1994 | 173 | 0.010 |
Why?
|
Platelet Count | 1 | 1996 | 780 | 0.010 |
Why?
|
Sheep | 2 | 1986 | 1437 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2003 | 2050 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1979 | 2377 | 0.010 |
Why?
|
Morbidity | 1 | 1998 | 1768 | 0.010 |
Why?
|
Ultrasonography | 1 | 1986 | 5984 | 0.010 |
Why?
|
Area Under Curve | 1 | 1997 | 1655 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 3493 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16367 | 0.010 |
Why?
|
Radiotherapy | 1 | 1979 | 1533 | 0.010 |
Why?
|
Methods | 1 | 1973 | 1129 | 0.010 |
Why?
|
Analgesics | 1 | 1979 | 1040 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14561 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1996 | 1588 | 0.010 |
Why?
|
Genetic Variation | 1 | 2007 | 6542 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1994 | 798 | 0.010 |
Why?
|
Vomiting | 1 | 1995 | 637 | 0.010 |
Why?
|
Debridement | 1 | 1994 | 492 | 0.010 |
Why?
|
Cough | 1 | 1995 | 555 | 0.010 |
Why?
|
Brain Ischemia | 1 | 1985 | 3265 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1997 | 3702 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2000 | 2455 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1995 | 1950 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1525 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1991 | 237 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2001 | 2949 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1996 | 2124 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21833 | 0.010 |
Why?
|
Drug Therapy | 1 | 1994 | 497 | 0.010 |
Why?
|
Verapamil | 1 | 1991 | 244 | 0.010 |
Why?
|
Median Eminence | 1 | 1990 | 37 | 0.010 |
Why?
|
Alopecia | 1 | 1994 | 382 | 0.010 |
Why?
|
Galanin | 1 | 1990 | 44 | 0.010 |
Why?
|
Insurance, Health | 1 | 2003 | 2494 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2003 | 2408 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2002 | 3589 | 0.010 |
Why?
|
Vena Cava Filters | 1 | 1993 | 253 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1101 | 0.010 |
Why?
|
Airway Obstruction | 1 | 1995 | 664 | 0.010 |
Why?
|
Proto-Oncogenes | 1 | 1990 | 321 | 0.010 |
Why?
|
Medicine | 1 | 1978 | 946 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2000 | 2727 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1995 | 1179 | 0.010 |
Why?
|
Antimony | 1 | 1989 | 19 | 0.010 |
Why?
|
Suture Techniques | 1 | 1994 | 798 | 0.010 |
Why?
|
Acetylcholine | 1 | 1991 | 621 | 0.010 |
Why?
|
Colloids | 1 | 1989 | 136 | 0.010 |
Why?
|
Technetium | 1 | 1989 | 334 | 0.010 |
Why?
|
Lipids | 1 | 2000 | 3307 | 0.010 |
Why?
|
Disabled Persons | 1 | 1998 | 1212 | 0.010 |
Why?
|
Golgi Apparatus | 1 | 1990 | 410 | 0.010 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1988 | 98 | 0.000 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1988 | 147 | 0.000 |
Why?
|
Follicle Stimulating Hormone, beta Subunit | 1 | 1987 | 58 | 0.000 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 2873 | 0.000 |
Why?
|
Blood Cells | 1 | 1989 | 309 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1990 | 610 | 0.000 |
Why?
|
Whole-Body Irradiation | 1 | 1988 | 449 | 0.000 |
Why?
|
Antigens, CD | 1 | 1998 | 4026 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1988 | 424 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1973 | 1877 | 0.000 |
Why?
|
Emergencies | 1 | 1994 | 1170 | 0.000 |
Why?
|
Headache | 1 | 1995 | 1226 | 0.000 |
Why?
|
Hyperplasia | 1 | 1990 | 1185 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 2001 | 7785 | 0.000 |
Why?
|
Vasodilation | 1 | 1991 | 944 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1995 | 1364 | 0.000 |
Why?
|
Cisterna Magna | 1 | 1986 | 41 | 0.000 |
Why?
|
Serotonin | 1 | 1991 | 1017 | 0.000 |
Why?
|
Constriction | 1 | 1986 | 181 | 0.000 |
Why?
|
Sodium Pertechnetate Tc 99m | 1 | 1985 | 57 | 0.000 |
Why?
|
Iodides | 1 | 1985 | 41 | 0.000 |
Why?
|
beta-Endorphin | 1 | 1985 | 53 | 0.000 |
Why?
|
Meningitis, Haemophilus | 1 | 1984 | 21 | 0.000 |
Why?
|
Receptors, Opioid | 1 | 1985 | 155 | 0.000 |
Why?
|
Radiation Dosage | 1 | 1994 | 1928 | 0.000 |
Why?
|
Ligation | 1 | 1986 | 453 | 0.000 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 1994 | 1624 | 0.000 |
Why?
|
Calcinosis | 1 | 1994 | 1499 | 0.000 |
Why?
|
Anticoagulants | 2 | 1993 | 4600 | 0.000 |
Why?
|
Serratia marcescens | 1 | 1984 | 45 | 0.000 |
Why?
|
Organ Size | 1 | 1990 | 2251 | 0.000 |
Why?
|
Palliative Care | 1 | 1979 | 3493 | 0.000 |
Why?
|
Dura Mater | 1 | 1986 | 291 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 2003 | 5692 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1979 | 4245 | 0.000 |
Why?
|
Coronary Artery Bypass | 1 | 1994 | 2288 | 0.000 |
Why?
|
Thyrotropin | 1 | 1987 | 849 | 0.000 |
Why?
|
Catheters, Indwelling | 1 | 1986 | 426 | 0.000 |
Why?
|
Klebsiella Infections | 1 | 1984 | 138 | 0.000 |
Why?
|
Chronic Disease | 1 | 1998 | 9145 | 0.000 |
Why?
|
Asthma | 1 | 2002 | 6010 | 0.000 |
Why?
|
Vertebral Artery | 1 | 1984 | 192 | 0.000 |
Why?
|
Wound Healing | 1 | 1994 | 2785 | 0.000 |
Why?
|
Vena Cava, Inferior | 1 | 1986 | 440 | 0.000 |
Why?
|
Klebsiella pneumoniae | 1 | 1984 | 251 | 0.000 |
Why?
|
Enterobacteriaceae Infections | 1 | 1984 | 187 | 0.000 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2000 | 5445 | 0.000 |
Why?
|
Perfusion | 1 | 1986 | 1360 | 0.000 |
Why?
|
Carotid Artery, Internal | 1 | 1984 | 445 | 0.000 |
Why?
|
Endothelium | 1 | 1984 | 778 | 0.000 |
Why?
|
Leukocytes | 1 | 1989 | 2045 | 0.000 |
Why?
|
Pons | 1 | 1982 | 245 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 11126 | 0.000 |
Why?
|
Catheterization | 1 | 1986 | 1470 | 0.000 |
Why?
|
Escherichia coli Infections | 1 | 1984 | 532 | 0.000 |
Why?
|
Cerebral Infarction | 1 | 1985 | 1011 | 0.000 |
Why?
|
Cell Membrane | 1 | 1989 | 3749 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1987 | 1257 | 0.000 |
Why?
|
Shock, Septic | 1 | 1986 | 775 | 0.000 |
Why?
|
Constriction, Pathologic | 1 | 1983 | 1107 | 0.000 |
Why?
|
Blood | 1 | 1980 | 598 | 0.000 |
Why?
|
Kinetics | 1 | 1985 | 6476 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1993 | 9955 | 0.000 |
Why?
|